Regenxbio
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $108,019 | $6,393 | $30,337 | $29,733 |
Gross Profit | 106,977 | -4,681 | 24,409 | -32,093 |
EBITDA | 34,259 | -77,486 | -51,004 | -44,886 |
EBIT | 30,502 | -81,343 | -54,873 | -48,772 |
Net Income | 22,709 | -90,051 | -67,149 | -61,941 |
Net Change In Cash | 108,019 | 6,393 | 30,337 | 29,733 |
Free Cash Flow | -62,998 | -77,421 | -52,798 | -56,451 |
Cash | 36,487 | 15,229 | 34,466 | 58,802 |
Basic Shares | 53,016 | 52,428 | 51,752 | 51,689 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $170,441 | $83,328 | $90,242 | $112,724 |
Gross Profit | 150,143 | 49,761 | 53,029 | 58,179 |
EBITDA | -133,255 | -198,228 | -239,464 | -244,242 |
EBIT | -148,870 | -214,443 | -256,784 | -257,151 |
Net Income | -193,878 | -227,102 | -263,494 | -280,321 |
Net Change In Cash | 170,441 | 83,328 | 90,242 | 112,724 |
Free Cash Flow | -126,377 | -175,561 | -228,367 | -238,212 |
Cash | 34,466 | 57,526 | 34,522 | 96,952 |
Basic Shares | 51,573 | 49,509 | 43,734 | 43,152 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $0.43 |
2026-03-31 | -$1.72 |
2025-12-31 | -$1.30 |
2025-09-30 | -$1.20 |